Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-915-2 | CAS number: 68390-97-6 This substance is identified by SDA Substance Name: C16-C18 alkyl dimethyl amine and SDA Reporting Number: 19-040-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Reliable studies on skin irritation/corrosion are available for the DMA category members C10-DMA, C12-DMA, C12-14-DMA, C14-DMA, C16-DMA, C12-18-DMA, C16-18-DMA, and C18-DMA. All studies were performed according to the OECD Guideline 404. The DMAs of this category caused skin irritant up to corrosive effects. Therefore, a classification as Skin Corr. 1B according to Regulation (EC) No 1272/2008 is warranted. No tendency related to increasing carbon chain length is observed.
Reliable in vivo studies on eye irritation/damage are available for the DMA category members C12-14-DMA, C14-DMA and C16-DMA. These studies were conducted according to the OECD Guideline 405. The DMAs of this category caused irreversible eye damaging effects. The substances of the DMA category have to be classified to cause irreversible damage to the eyes (Cat. 1) following the criteria of Regulation (EC) No. 1272/2008. No tendency related to increasing carbon chain length is observed. As endpoint conclusion the most conservative value for the category members is selected.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- From 24 SEP 1987 to 10 NOV 1987
- Justification for type of information:
- For details on endpoint-specific justification, please see read-across justification document (category approach) in the linked category of dimethylalkylamines.
- Irritation parameter:
- erythema score
- Basis:
- mean
- Remarks:
- test item exposure: 4 h
- Time point:
- 24/48/72 h
- Score:
- 4
- Max. score:
- 4
- Reversibility:
- other: reversibiliy cannot be determined due to other skin effects
- Remarks on result:
- other: effects after 14 days: glossy skin, desquamation
- Irritation parameter:
- edema score
- Basis:
- animal #1
- Remarks:
- test item exposure: 4h
- Time point:
- 24/48/72 h
- Score:
- 3.7
- Max. score:
- 4
- Reversibility:
- fully reversible within: 14 days
- Irritation parameter:
- edema score
- Basis:
- mean
- Remarks:
- animal #2 and #3, test item exposure: 4 h
- Time point:
- 24/48/72 h
- Score:
- 3.3
- Max. score:
- 4
- Reversibility:
- fully reversible within: 14 days
- Executive summary:
The study used as source investigated skin irritation/corrosion of C12-18 DMA. The study results of the source compound were considered applicable to the target compound. Justification and applicability of the read-across approach (category approach) is outlined in the read-across report in the linked category of dimethylalkylamines.
Reference
Results presented above were obtained with the source substance C12-18 DMA.
Additional results for C12-18 DMA:
three minutes exposure
Skin reaction | Reading (hours) | Individual scores - rabbit number 1 -3 | ||
Erythema / eschar formation | 1 | 1 | 1 | 1 |
24 | 2 | 2 | 2 | |
48 | 2 | 2 | 2 | |
72 | 2 D | 3 D | 2 D | |
7 Days | HyCrTL | HyCrTL | HyCr | |
14 Days | 0 | 0 | 0 | |
Oedema formation | 1 | 1 | 1 | 1 |
24 | 2 | 2 | 2 | |
48 | 2 | 2 | 1 | |
72 | 2 | 2 | 1 | |
7 Days | 0 | 0 | 0 | |
14 Days | 0 | 0 | 0 | |
One hour exposure
Skin reaction | Reading (hours) | Individual scores - rabbit number 1 -3 | ||
Erythema / eschar formation | 1 | 2 | 1 | 1 |
24 | 2 Br | 2 | 2 Br | |
48 | 2 Br | 2 | 2 Br | |
72 | 2 Br | 2 | 2 Br | |
7 Days | HyCrTL | HyTL | HyCrTL | |
14 Days | Fa | FaD | Fa | |
Oedema formation | 1 | 2 | 1 | 1 |
24 | 2 | 2 | 2 | |
48 | 2 | 2 | 2 | |
72 | 2 | 2 | 2 | |
7 Days | 0 | 0 | 0 | |
14 Days | 0 | 0 | 0 |
four hour exposure
Skin reaction | Reading (hours) | Individual scores - rabbit number 4 -6 | ||
Erythema / eschar formation | 1 | 2 H | 2 H | 2 H |
24 | 4 MBE | 4 EMB | 4 EMB | |
48 | 4 WBHE | 4 EMB | 4 EMB | |
72 | 4 WBE | 4 EWB | 4 EMB | |
7 Days | EHY | Eg | BsEgHy | |
14 Days | GsD | GsD | GsD | |
Total 24, 48 and 72 hours | 12 | 12 | 12 | |
Mean Values | 4 | 4 | 4 | |
Oedema formation | 1 | 4 0e | 4 0e | 3 |
24 | 4 0e | 4 0e | 4 0e | |
48 | 4 0e | 3 0e | 3 0e | |
72 | 3 | 3 | 3 | |
7 Days | 1 | 1 | 0 | |
14 Days | 0 | 0 | 0 | |
Total 24, 48 and 72 hours | 11 | 10 | 10 | |
Mean Values | 3,7 | 3,3 | 3,3 |
B = blanching of skin surrounding treatment site
Fa = abnormal fur growth - fur growing in various directions
Br= brown areas over treatment site
0e= oedema extending ventrally beyond site
D= desquamation
Hy= dry, straw-coloured skin (possible hyperkeratinisation)
Cr= superficial cracking of skin
T= thickening of skin
L= loss of skin suppleness
M= moderate to severe erythema extending beyond treatment site
W= well-definded erythe,a extending beyond treatment site
E= eschar of dry, straw-coloured sin (possible hyperkeratinsation) surrounding eschar
Eg= eschar lifting to reveal glossy skin
Bs= focal areas of dried, blood stained tissue
Gs= glossy skin
D= desquamation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (corrosive)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Justification for type of information:
- For details on endpoint-specific justification, please see read-across justification document (category approach) in the linked category of dimethylalkylamines.
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 4
- Remarks on result:
- other: no effects observed
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0.67
- Max. score:
- 2
- Reversibility:
- not fully reversible within: 22 days
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 22 days
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 1.23
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 22 days
- Executive summary:
The study used as source investigated eye irritation/corrosion of C16-DMA. The study results of the source compound were considered applicable to the target compound. Justification and applicability of the read-across approach (category approach) is outlined in the read-across report in the linked category of dimethylalkylamines.
Reference
Results presented above were obtained with the source substance C16-DMA.
Additional results for C16-DMA:
Mean valuea for occulat lesions 24, 48 and 72 h after instillation
Animal number and sex | Corneal opacity | Iridial lesions | Redness of Conjunctiva | Chemosis |
27TK490F | 0 | 1 | 1 | 2 |
27TK533F | 0 | 1 | 1 | 0,7 |
27TK534F | 0 | 0 | 1 | 1 |
Grades for occular irritation responses
Animal No. and Sex: 27TK490F# | Pain evaluation response: 0 |
|
|
| ||||
Region of | Response |
| Grade of response at time alter instillation Hours Days |
| ||||
1 | 24 | 48 | 72 | 8 | 15 | 22 | ||
Comea | Opacity | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Area | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ulceration |
|
|
|
|
|
|
|
| Stippling |
|
|
|
|
|
|
|
Iris | Value | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Conjunctiva | Redness | 2 | 1 | 1 | 1 | * | * | 1 |
| Chemosis | 0 | 2 | 2 | 2A | OA | OA | 0 |
| Discharge | 2 | 1 | 1 | 2 | * | * | 1 |
| Necrosis | - |
|
|
|
|
|
|
| Ulceration | - | - |
|
|
|
|
|
BC | BC |
Grades for occular irritation responses
Animal No. and Sex: 27TK534F | Pain evaluation response: 0 |
|
|
| ||||
Region of | Response |
| Grade of response at time alter instillation Hours Days |
| ||||
1 | 24 | 48 | 72 | 8 | 15 | 22 | ||
Cornea | Opacity | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Area | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ulceration |
|
|
|
|
|
|
|
| Stippling |
|
|
|
|
|
| - |
Iris | Value | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Conjunctiva | Redness | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Chemosis | I | 2A | IA | OA | OA | OA | 0 |
| Discharge | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
| Necrosis |
|
|
|
|
|
|
|
| Ulceration |
|
|
|
|
|
|
|
BC | BC |
#Sentinel animal
* Impossible to open eye sufficiently to assess
A Blepharitis
B Peri-orbital exfoliation
C Peri-orbital hair loss
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irreversible damage)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Eighteen reliable in vivo skin irritation studies (reliability 1) are available for C10-DMA, C12-DMA, C12-14-DMA, C14-DMA, C16-DMA, C12-18-DMA, C16-18-DMA and C18-DMA. All studies were performed according to the OECD Guideline 404.
Additionally, for C12-14-DMA and for C16-18-DMA reliable in vitro studies according to OECD 431 are available. For C16-DMA and C12-18-DMA, three studies of lower reliability (reliability 3) are reported as well.
In six reliable studies the results are indicating that the test substances are irritating to skin (C10-DMA, C12-DMA, C14-DMA, C16-DMA, C18-DMA). Except for C14-DMA and C18-DMA, for which only irritant effects were observed, additional studies for the other substances also point to corrosive effects. Altogether, there are twelve reliable studies indicating a corrosive effect of the test substances on the skin.
Only four of these twelve studies were performed with exposure times ≤ 4 h and observation periods of at least 14 days allowing a more detailed classification in corrosive subcategories 1A, 1B or 1C according to Regulation (EC) No. 1272/2008. These studies point to subcategory 1A for C12-DMA, subcategory 1B for C12-18-DMA and subcategory 1C for C12-18-DMA (2 studies) as well. The studies for the subcategories show slight differences, for which the reasons are not obvious, as all studies were reliable and according to OECD guidelines. The differences are possibly due to biological variance. The most contradicting results were obtained for C12-DMA: one study indicating subcategory 1A and another one revealed only irritating effects. The study with the corrosive effects after 3 minutes exposure was possibly an outlier. C12-18-DMA was found to be corrosive in one study after 1 h of exposure (subcategory 1B) and in two other studies after 4 hours of exposure (subcategory 1C). Besides other effects, scar formation was observed in animals treated for one hour indicating that the substance induces skin corrosion already after short-term exposure. Altogether, across the substances belonging to the DMA category, the study results are comparable and an effect correlation to the alkyl chain length could not be derived. After four hours skin exposure to DMAs, the animals exhibited initially erythema and edema (slight to severe) followed by skin alterations such as eschar formation, thickening of the skin, incrustation up to scar formation etc., indicating severe skin damage.
The three non-reliable studies (reliability 3) could not be used for classification due to the short observation time of 48 h. However, within these 48 h of observation, serious effects were observed indicating corrosive properties of the test substances, supporting the results from the reliable studies.
The data reported in the in vitro tests are contradicting the results observed in vivo. In tests according to OECD guideline 431, a corrosive potential of test substances can be assessed in reconstructed human epidermis. For C12-14-DMA and C16-18-DMA, non-corrosiveness was observed in this test. However, due to the strong evidence of corrosiveness in vivo, the results of these test are not considered relevant for classification.
Based on the available in vivo data, it is concluded that the substances of the DMA-category should be classified as skin corrosive (subcategory 1B) according to Regulation (EC) No. 1272/2008 (CLP). A classification as skin corrosive (subcategory 1A) does not seem to be justified as this single finding for one substance was not confirmed by studies with other members of the category and contradicted by a second study for the same substance, which indicated only irritating effects.
Four reliable in vivo eye irritation studies (reliability 1) are available for C12-14-DMA, C14-DMA and C16-DMA. These studies were conducted according to the OECD Guideline 405.
In all four studies the treatment related effects are comparable: the primary effects observed in the first week were iritis and conjunctivitis followed by blepharitis in the second and third week. Towards end of the observation period the treated animals displayed peri-orbital exfoliation, peri-orbital hair loss and peri-orbital sloughing. The treatment related effects were not fully reversible within 14 days or even longer observation times, i.e. the substances caused irreversible damage to the eyes.
For C12-14-DMA and C16-18-DMA four reliable in vitro eye irritation/corrosion tests were performed. For each substance one test was performed according to OECD guideline 437 and another one with EpiOcular™ which is a three-dimensional in vitro model of the human corneal epithelium. The results of these tests are contradicting for each substance: One test showed irritating results, the other non-irritating (For C12-14-DMA the OECD test result was “irritant”, the EpiOcular™ test showed non-irritant effects, for C16-18-DMA vice versa).
However due to the strong evidence of corrosiveness of C12-14-DMA and C16-18-DMA in in vivo skin studies and the irreversible damage to the eyes observed for the other members of the DMA category, the less severe effects observed for C12-14-DMA and C16-18-DMA in these in vitro tests are not considered relevant for classification. Taking into account the severe effects on the eye observed in the available in vivo studies as well as the skin corrosive properties of these substances, DMA category members have to be classified as causing irreversible damage to the eyes (category 1).
No studies are available to evaluate respiratory irritation.
Justification for classification or non-classification
According to the results of available studies for the members of the DMA category, these substances are already corrosive to skin after exposure times of > 3 minutes and ≤ 1 h. Therefore, they fulfil the criteria to be classified as skin corrosive substance (subcategory 1B) following the criteria of Regulation (EC) No. 1272/2008 (CLP) and should be classified as corrosive according to Council Directive 67/548/EEC (R34).
According to the results of available studies for the members of the DMA category, the substances of the DMA category have to be classified to cause irreversible damage to the eyes (Cat. 1) following the criteria of Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.